blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2890697

EP2890697 - PSEUDOURIDIMYCIN (PUM) AND ITS DERIVATES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2018
Database last updated on 10.07.2024
FormerThe patent has been granted
Status updated on  04.08.2017
FormerGrant of patent is intended
Status updated on  22.02.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Naicons Srl
Viale Ortles 22/4
20138 Milano / IT
[2015/30]
Former [2015/28]For all designated states
New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
20138 Milano (MI) / IT
Inventor(s)01 / MAFFIOLI, Sonia
Viale Brianza, 35
I-20127 Milano MI / IT
02 / CANDIANI, Gianpaolo
Via Bellini 2C
I-20064 Gorgonzola (MI) / IT
03 / GUGLIERAME, Paola
Via Madonnina 44
I-27010 Cura Carpignano (PV) / IT
04 / MONCIARDINI, Paolo
Via L. Sturzo, 212
I-21040 Cislago VA / IT
05 / SERINA, Stefania
Via Palanzone 18
I-20162 Milano (MI) / IT
06 / DONADIO, Stefano
Via Monte Morone 1
I-21046 Malnate VA / IT
 [2017/36]
Former [2015/35]01 / MAFFIOLI, Sonia
Viale Brianza, 35
I-20127 Milano MI / IT
02 / CANDIANI, Gianpaolo
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
03 / GUGLIERAME, Paola
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
04 / MONCIARDINI, Paolo
Via L. Sturzo, 212
I-21040 Cislago VA / IT
05 / SERINA, Stefania
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
06 / DONADIO, Stefano
Via Monte Morone 1
I-21046 Malnate VA / IT
Former [2015/28]01 / MAFFIOLI, Sonia
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
02 / CANDIANI, Gianpaolo
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
03 / GUGLIERAME, Paola
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
04 / MONCIARDINI, Paolo
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
05 / SERINA, Stefania
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
06 / DONADIO, Stefano
c/o New Anti-Infectives Consortium S.C.A.R.L.
Via Fantoli Gaudenzio 16/15
I-20138 Milano (MI) / IT
Representative(s)Trupiano, Federica
Marietti, Gislon e Trupiano S.r.l.
Via Larga, 16
20122 Milano / IT
[2015/28]
Application number, filing date13758972.705.07.2013
[2017/36]
WO2013IB01473
Priority number, dateIT2012MI0142509.08.2012         Original published format: IT MI20121425
[2015/28]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014024013
Date:13.02.2014
Language:EN
[2014/07]
Type: A1 Application with search report 
No.:EP2890697
Date:08.07.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 13.02.2014 takes the place of the publication of the European patent application.
[2015/28]
Type: B1 Patent specification 
No.:EP2890697
Date:06.09.2017
Language:EN
[2017/36]
Search report(s)International search report - published on:EP13.02.2014
ClassificationIPC:C07K1/06, C07K9/00, A61K31/7004, C12P17/16, C12R1/465
[2017/11]
CPC:
C12P17/16 (EP,US); C07K9/001 (US); C07K1/061 (US);
C12N1/205 (EP,US); A61K38/00 (US); C12R2001/465 (EP,US)
Former IPC [2015/28]C07D405/04, C12N1/20, A61K31/513, A61K31/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/28]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PSEUDOURIDIMYCIN (PUM) UND SEINE DERIVATE[2015/28]
English:PSEUDOURIDIMYCIN (PUM) AND ITS DERIVATES[2015/28]
French:PSEUDO-URIDIMYCINE (PUM) ET SES DÉRIVÉS[2015/28]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase04.03.2015National basic fee paid 
04.03.2015Designation fee(s) paid 
04.03.2015Examination fee paid 
Examination procedure04.03.2015Examination requested  [2015/28]
15.12.2015Amendment by applicant (claims and/or description)
23.02.2017Communication of intention to grant the patent
26.06.2017Fee for grant paid
26.06.2017Fee for publishing/printing paid
26.06.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.02.2017
Opposition(s)07.06.2018No opposition filed within time limit [2018/33]
Fees paidRenewal fee
25.06.2015Renewal fee patent year 03
21.07.2016Renewal fee patent year 04
27.07.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.07.2013
AL06.09.2017
AT06.09.2017
CY06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
MK06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
[2020/34]
Former [2020/31]HU05.07.2013
AT06.09.2017
CY06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
MK06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/30]HU05.07.2013
AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/28]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/16]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
TR06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2019/15]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/40]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/35]AT06.09.2017
CZ06.09.2017
DK06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/24]AT06.09.2017
CZ06.09.2017
EE06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
PL06.09.2017
RO06.09.2017
RS06.09.2017
SE06.09.2017
SK06.09.2017
SM06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/21]CZ06.09.2017
ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/15]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
NL06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/12]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
LV06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/11]ES06.09.2017
FI06.09.2017
HR06.09.2017
LT06.09.2017
RS06.09.2017
SE06.09.2017
BG06.12.2017
NO06.12.2017
GR07.12.2017
Former [2018/09]FI06.09.2017
LT06.09.2017
SE06.09.2017
NO06.12.2017
Former [2018/08]FI06.09.2017
LT06.09.2017
NO06.12.2017
Former [2018/07]LT06.09.2017
NO06.12.2017
Cited inInternational search[A]  - EDUARDO KRAINER ET AL, "Synthesis and biological evaluation of dipeptidyl and tripeptidyl polyoxin and nikkomycin analogs as anticandidal prodrugs", JOURNAL OF MEDICINAL CHEMISTRY, (19910101), vol. 34, no. 1, doi:10.1021/jm00105a026, ISSN 0022-2623, pages 174 - 180, XP055045809 [A] 1,5,6,9,10 * page 175; table I; compound 2 *

DOI:   http://dx.doi.org/10.1021/jm00105a026
by applicant   - QI Y; HULETT FM., MOL. MICROBIOL., (1998), vol. 28, no. 6, pages 1187 - 1197
    - DIGNAM JD; LEBOVITZ RM; ROEDER RG., NUCLEIC ACIDS RES., (1983), vol. 11, no. 5, pages 1475 - 89
    - MARIANI R; GRANATA G; MAFFIOLI SI; SERINA S; BRUNATI C; SOSIO M; MARAZZI A; VANNINI A; PATEL D; WHITE R, BIOORG MED CHEM LETT., (2005), vol. 15, no. 16, pages 3748 - 3752
    - HOLOWACHUKA S; BAL'AB M; BUDDINGTON R., J. MICROBIOL. METH., (2003), vol. 55, pages 441 - 446
    - "The Spearman-Kaxber method", FINNEY, D.J., Statistical method in biological assay, CHARLES GRIFFIN & COMPANY LIMITED, (1952), pages 524 - 30
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.